sarpogrelate has been researched along with Coronary Disease in 2 studies
sarpogrelate: structure given in first source
Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Horibe, E | 1 |
| Nishigaki, K | 1 |
| Minatoguchi, S | 1 |
| Fujiwara, H | 1 |
| Satomura, K | 1 |
| Takase, B | 1 |
| Hamabe, A | 1 |
| Ashida, K | 1 |
| Hosaka, H | 1 |
| Ohsuzu, F | 1 |
| Kurita, A | 1 |
2 trials available for sarpogrelate and Coronary Disease
| Article | Year |
|---|---|
Sarpogrelate, a 5-HT2 receptor blocker, may have a preconditioning-like effect in patients with coronary artery disease.
Topics: Blood Pressure; Collateral Circulation; Coronary Disease; Electrocardiography; Female; Heart Rate; H | 2004 |
Sarpogrelate, a specific 5HT2-receptor antagonist, improves the coronary microcirculation in coronary artery disease.
Topics: Aged; Coronary Circulation; Coronary Disease; Coronary Vessels; Cross-Over Studies; Dose-Response Re | 2002 |